Abstracts Discussing The Treatment Of Peyronie's Disease - Reported From The Annual Meeting Of The American Urological Association

Main Category: Urology / Nephrology
Article Date: 06 Jul 2008 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

ORLANDO, FL (UroToday.com) - Several abstracts discussed the treatment of Peyronie's disease. The vast majority of men will have medical management for their Peyronie's disease.

There were no discernible predictive factors for those men who have a good or bad outcome. Shockwave therapy was not effective in Peyronie's disease. However, after surgical correction of the plaque, men experience less stress and an improvement in psychosocial factors. Penile extenders were not found effective.

Erectile dysfunction is more likely in men receiving brachytherapy if the penile bulb receives more than 52 Gy. Ejaculatory function is preserved in 70% of patients with prostate cancer treated by brachytherapy. Age, diabetes, and whether a bilateral nerve sparing procedure was done are predictive factors for potency after radical prostatectomy. Men with better pre-operative SHIM scores and those that recovery sexual function early have to best chance of being sexually active 2 years after radical prostatectomy.

If there is even mild erectile dysfunction pre-operatively, the chances of retaining potency after radical prostatectomy is low. Also, recovery of urinary function is related to return of sexual function.

Presented by Ajay Nehra, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.

Reported by UroToday.com Contributing Editor David P. Wood, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday